AnalystBook Research · Company Intelligence

VOLITIONRX LTD

VNRXNYSE

Built from VOLITIONRX LTD's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

The read at a glance

Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.

  • Earnings-manipulation signal · Beneish M -3.90 no flag raisedOK
  • Earnings quality 43/100 worth a closer lookWatch

Leadership changes

From VOLITIONRX LTD's own filings, the day they're filed.

  • VolitionRx Limited · Directors · departureeff. 2026-05-12
  • Mickie Henshall · Directors · departureeff. 2026-05-12
  • Volition Veterinary · Chief Executive Officer · departureeff. 2026-01-31

Latest filings

  • 8-K · Company announcement2026-09-02
  • 8-K · Company announcement2026-09-02
  • 8-K · Company announcement2026-08-24
  • 10-Q · Quarterly report2026-08-13
  • 8-K · Company announcement2026-08-13
In the full recordFree for 14 days
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about VOLITIONRX LTD, every answer cited to the official filings🔒
  • The Intelligence Brief — added when VOLITIONRX LTD's brief passes our SEC-figure check🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.